DeepMind’s Latest AlphaFold AI Model Rev...

A 19-year-old founder just raised $3 million from Google executives to build Supermemory, an AI startup redefining how digital memory works. His bold vision is turning heads across Silicon Valley.Get the top 40+ AI Models for $20 at AI Box: ⁠⁠https://aibox.aiAI Chat YouTube Chann ... Show More

OpenAI and AMD have signed a multi-year chip deal which may generate tens of billions in revenue for AMD, helping accelerate their momentum in the AI chips industry. Get the top 40+ AI Models for $20 at AI Box: ⁠⁠https://aibox.aiAI Chat YouTube Channel: https://www.youtube.com/@J ... Show More

Here are my favorite top AI news stories you may have missed from last week! Get the top 40+ AI Models for $20 at AI Box: ⁠⁠https://aibox.aiAI Chat YouTube Channel: https://www.youtube.com/@JaedenSchaferJoin my AI Hustle Community: https://www.skool.com/aihustle 

"Pharmaceutical Breakthroughs: The Cutting Edge of Biotechnology" - In this episode, we dive deep into the revolutionary world of biotechnology and its transformative impact on pharmaceuticals. Discover how cutting-edge innovations are reshaping drug development, accelerating vac ... Show More

Max Jaderberg and Sergei Yakneen from Isomorphic Labs discuss how AI is enhancing drug discovery by treating biology as an information processing system. They share how advanced AI models like AlphaFold 3 are accelerating the pipeline and paving the way for a future of precision ... Show More

Why is the process of creating a new and highly beneficial pharmaceutical drug so difficult? What are the hurdles researchers face when trying to identify a new drug? Why are side effects so challenging to predict? Why are pharmaceutical drugs so expensive? In today's episode, we ... Show More

Today’s guest is Nishtha Jain, Head of Innovation and Digital Technology at Takeda Pharmaceuticals. Nistha returns to the program to discuss the transformative impact of AI across the pharmaceutical value chain. She and Emerj Editorial Director Matthew DeMello explore how AI is i ... Show More

Greg Meyers, chief digital and technology officer at Bristol Myers Squibb, explains how AI is transforming pharmaceutical research from hypothesis-driven hunches to data-driven discoveries. Learn how the company is using computational chemistry to engineer breakthrough therapies ... Show More

In this episode, we explore OpenAI's new SearchGPT model and its potential to challenge Google and Perplexity in the search engine landscape. We discuss the features and capabilities that set SearchGPT apart as OpenAI's latest innovation in AI-powered search. Get on the AI Box Wa ... Show More

Can AI compress the years long research time of a PhD into seconds? Research scientist Max Jaderberg explores how “AI analogs” simulate real-world lab work with staggering speed and scale, unlocking new insights on protein folding and drug discovery. Drawing on his experience wor ... Show More

GSK’s Chief Digital and Technology Officer Shobie Ramakrishnan discusses how the company is leveraging AI and data models for vaccine development and drug discovery in this episode of Bloomberg Intelligence’s Tech Disruptors podcast. BI’s Health-Care Analyst Sam Fazeli and Techno ... Show More

Today’s guest is Liran Belenzon, Co-founder and CEO of BenchSci. BenchSci is a global leader in AI solutions for preclinical R&D that helps decipher complex biomedical research using proprietary technology. Liran joins us to discuss how AI is transforming disease biology research ... Show More

Former OpenAI researcher Leopold Aschenbrenner has released a series of essays talking about how he sees AI playing out and what we should all do about it. Pete digs into his extremely impressive background and his arguments around why we’re about to get AGI. Transcripts: ⁠https: ... Show More